Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Subject collections
    • Interviews
    • Sign up for alerts
  • About us
    • About DMM
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Outstanding paper prize
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact DMM
    • Advertising
    • Feedback
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

User menu

  • Log in

Search

  • Advanced search
Disease Models & Mechanisms
  • COB
    • About The Company of Biologists
    • Development
    • Journal of Cell Science
    • Journal of Experimental Biology
    • Disease Models & Mechanisms
    • Biology Open

supporting biologistsinspiring biology

Disease Models & Mechanisms

Advanced search

RSS   Twitter   Facebook   YouTube

  • Home
  • Articles
    • Accepted manuscripts
    • Issue in progress
    • Latest complete issue
    • Issue archive
    • Archive by article type
    • Subject collections
    • Interviews
    • Sign up for alerts
  • About us
    • About DMM
    • Editors and Board
    • Editor biographies
    • Travelling Fellowships
    • Grants and funding
    • Journal Meetings
    • Workshops
    • The Company of Biologists
    • Journal news
  • For authors
    • Submit a manuscript
    • Aims and scope
    • Presubmission enquiries
    • Article types
    • Manuscript preparation
    • Cover suggestions
    • Editorial process
    • Promoting your paper
    • Open Access
    • Outstanding paper prize
    • Biology Open transfer
  • Journal info
    • Journal policies
    • Rights and permissions
    • Media policies
    • Reviewer guide
    • Sign up for alerts
  • Contact
    • Contact DMM
    • Advertising
    • Feedback
Research Article
Phenotypic rescue of a Drosophila model of mitochondrial ANT1 disease
Suvi Vartiainen, Shanjun Chen, Jack George, Tea Tuomela, Kaisa R. Luoto, Kevin M. C. O’Dell, Howard T. Jacobs
Disease Models & Mechanisms 2014 7: 635-648; doi: 10.1242/dmm.016527
Suvi Vartiainen
1BioMediTech and Tampere University Hospital, FI-33014 University of Tampere, Finland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shanjun Chen
1BioMediTech and Tampere University Hospital, FI-33014 University of Tampere, Finland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jack George
1BioMediTech and Tampere University Hospital, FI-33014 University of Tampere, Finland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tea Tuomela
1BioMediTech and Tampere University Hospital, FI-33014 University of Tampere, Finland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kaisa R. Luoto
1BioMediTech and Tampere University Hospital, FI-33014 University of Tampere, Finland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin M. C. O’Dell
2Institute of Molecular, Cell and Systems Biology, University of Glasgow, Glasgow G12 8QQ, Scotland, UK.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Howard T. Jacobs
1BioMediTech and Tampere University Hospital, FI-33014 University of Tampere, Finland.
3Research Program of Molecular Neurology, FI-00014 University of Helsinki, Finland.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: howard.t.jacobs@uta.fi
  • Article
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF
Loading

Abstract

A point mutation in the Drosophila gene that codes for the major adult isoform of adenine nuclear translocase (ANT) represents a model for human diseases that are associated with ANT insufficiency [stress-sensitive B1 (sesB1)]. We characterized the organismal, bioenergetic and molecular phenotype of sesB1 flies then tested strategies to compensate the mutant phenotype. In addition to developmental delay and mechanical-stress-induced seizures, sesB1 flies have an impaired response to sound, defective male courtship, female sterility and curtailed lifespan. These phenotypes, excluding the latter two, are shared with the mitoribosomal protein S12 mutant, tko25t. Mitochondria from sesB1 adults showed a decreased respiratory control ratio and downregulation of cytochrome oxidase. sesB1 adults exhibited ATP depletion, lactate accumulation and changes in gene expression that were consistent with a metabolic shift towards glycolysis, characterized by activation of lactate dehydrogenase and anaplerotic pathways. Females also showed downregulation of many genes that are required for oogenesis, and their eggs, although fertilized, failed to develop to the larval stages. The sesB1 phenotypes of developmental delay and mechanical-stress-induced seizures were alleviated by an altered mitochondrial DNA background. Female sterility was substantially rescued by somatic expression of alternative oxidase (AOX) from the sea squirt Ciona intestinalis, whereas AOX did not alleviate developmental delay. Our findings illustrate the potential of different therapeutic strategies for ANT-linked diseases, based on alleviating metabolic stress.

INTRODUCTION

Drosophila melanogaster is a convenient animal model for human genetic diseases, including those that are associated with mitochondrial dysfunction. Autosomal dominant progressive external ophthalmoplegia (adPEO) is a relatively common presentation of mitochondrial disease and is associated with multiple mitochondrial (mt)DNA deletions in muscle and other tissues (Suomalainen and Kaukonen, 2001). It is caused, typically, by single gene mutations in nuclear genes that are directly, or indirectly, involved in mtDNA maintenance – including those encoding the two subunits of DNA polymerase γ, POLG1 (Van Goethem et al., 2001) and POLG2 (Longley et al., 2006), the mitochondrial helicase Twinkle (C10orf2) (Spelbrink et al., 2001), the ribonucleotide reductase small subunit RRM2B (Tyynismaa et al., 2009) and the muscle-specific isoform of the adenine nucleotide translocase ANT1/SLC25A4 (Kaukonen et al., 2000). adPEO-causing mutations have been mapped to different regions of the ANT1 coding sequence (Kaukonen et al., 2000; Napoli et al., 2001; Komaki et al., 2002; Deschauer et al., 2005). Functional studies of two such mutants – A114P and V289M – in cultured myotubes revealed that, for a given mitochondrial inner membrane potential, the rate of adenine nucleotide exchange was substantially decreased, and, under some conditions, the reversed transport of ATP into mitochondria was predicted to occur readily (Kawamata et al., 2011). Earlier modeling of these mutants in yeast (Fontanesi et al., 2004) also concluded that they impair translocase activity and lead to a defect in oxidative phosphorylation (OXPHOS). ANT1 encodes the major isoform of the translocase that is found in post-mitotic tissues – such as the heart, skeletal muscle and brain – whereas three other isogenes encode isoforms of the translocase in other cells and tissues (Chevrollier et al., 2011).

AdPEO is a late-onset disorder, but ANT1 mutations are also associated with more severe early-onset diseases that show recessive inheritance. These include mitochondrial myopathy and cardiomyopathy due to complete, or almost complete, loss of translocase function (Palmieri et al., 2005), which also manifests in mice in which Ant1 has been knocked out (Graham et al., 1997; Narula et al., 2011). ANT1 deficiency has also been proposed to be a major contributor to the clinical features of Sengers syndrome, which comprises congenital cataract, hypertrophic cardiomyopathy and skeletal myopathy (Jordens et al., 2002). In this case, the effects on ANT1 are secondary because the primary mutation is in AGK, encoding acylglycerol kinase (Mayr et al., 2012), which results in mitochondrial phospholipid defects. Dysregulation of ANT1 has also been suggested to be involved in the pathogenesis of inclusion-body myositis (Barca et al., 2013) and Rett syndrome (Forlani et al., 2010).

The molecular pathology of ANT1-associated disease has been extensively studied using samples taken from affected individuals, as well as using the Ant1-knockout mouse. However, these studies have certain limitations; in human cells, the ability to recapitulate the exact in vivo physiological conditions in affected tissues – for example, the failing heart – is severely limited. As indicated above, Ant1-knockout mice exhibit dilated cardiomyopathy that is associated with a progressive decline of cardiac functions, ending in chronic heart failure (Narula et al., 2011). Conversely, Ant1 overexpression is cardioprotective (Wang et al., 2009). The knockout exhibits lactic acidosis and the hyperproliferation of abnormal mitochondria in muscle (Graham et al., 1997). The increased production of reactive oxygen species (ROS) in mitochondria that have been isolated from the affected tissues of knockout animals is also associated with mitochondrial genomic damage (Esposito et al., 1999). More surprisingly, loss of Ant1 in the brain entrains increased mitochondrial membrane potential and resistance to apoptosis, leading to the suggestion that the protein confers natural susceptibility to excitotoxicity (Lee et al., 2009). Muscle mitochondria from the knockout mouse show decreased proton leak (Brand et al., 2005), which might explain these observations, but does not necessarily elucidate the functional consequences of pathological mutations.

TRANSLATIONAL IMPACT

Clinical issue

A variety of genetic mutations have been implicated in mitochondrial myopathies, which are characterized by muscular weakness and neurological abnormalities. One cause of mitochondrial myopathy is mutation of the gene that codes for the adenine nucleotide translocase (ANT). ANT is the transporter protein that shuttles ADP and ATP across the inner mitochondrial membrane, enabling the energy released from catabolism to be made available to the rest of the cell. ANT deficiency could be a common manifestation of mitochondrial disease, because it can also be produced by other abnormalities affecting the organelle; for example, defects in the mitochondrial membrane phospholipid composition. In this study, the authors used Drosophila to explore the effects of ANT deficiency and test possible strategies to overcome the defect.

Results

The authors characterized the phenotype of sesB1 mutant flies, which carry a mutation in the major ANT-encoding gene of Drosophila. Mutant flies were profiled at the organismal (developmental, behavioral), metabolic and molecular genetic levels. sesB1 flies showed developmental retardation, epileptic seizures upon mechanical stress, hearing impairment, female sterility, defective male courtship and greatly decreased lifespan. There was an accumulation of lactate, an end-product of glucose breakdown that is potentially toxic at high concentrations. The expression of many genes for metabolic functions was altered, and, in females, many genes involved in egg production were downregulated. The authors showed that developmental delay and seizures could be partially alleviated by transferring the sesB1 mutation to a mitochondrial DNA background that is thought to increase mitochondrial biogenesis. A minor effect on the sensitivity of mutant flies to mechanical-stress-induced seizures was produced by increased expression of the fly homolog of PGC1-α, the proposed ‘master regulator’ of mitochondrial biogenesis. Female sterility, but not the other phenotypes, was substantially rescued by expression of the alternative oxidase (AOX) from the sea squirt Ciona intestinalis, which has previously been shown to mitigate oxidative stress caused by mitochondrial inhibition.

Implications and future directions

The authors’ comprehensive analysis of sesB1 mutant flies demonstrates that ANT deficiency causes a host of developmental and neurological phenotypes that are underpinned by abnormalities in metabolism. They provide evidence that pharmacological strategies aimed at boosting mitochondrial biogenesis, as well as genetic therapies based on AOX, could be effective treatments for mitochondrial myopathies and other human diseases that are associated with ANT deficiency. A useful next step will be to analyze in more detail the mechanisms by which these interventions alleviate the disease-like features of sesB1 flies, with the aim of eventually translating these findings to human therapies.

The Ant1-knockout mouse represents, by definition, complete loss of function, which does not appear to be the case for human ANT1 in disease, except in rare cases (Palmieri et al., 2005). However, the fact that ANT is encoded in mammals by a multigene family means that the knockout of one isoform might entrain effects on the regulation of others, which can also compensate for any defect. This has been hypothesized to account for the lack of retinal pathology in the Ant1-knockout mouse (Phillips et al., 2010). For these reasons, a more appropriate model is required that is based on actual disease-relevant mutations and in which the effects of genetic redundancy can be set aside.

In Drosophila, ANT is also encoded by a small gene family. In this case, however, the major isoform, which is encoded by the gene stress-sensitive B (sesB; FlyBase annotation CG16944), is ubiquitously expressed at a high level, whereas the mRNA for the second isogene, Ant2 (FlyBase annotation CG1683), is found only at low levels, except in testis (www.flyatlas.org). A mutant allele of sesB, sesB1, exhibits a phenotype of susceptibility to mechanical-stress-induced seizures (‘bang sensitivity’) and developmental delay (Zhang et al., 1999), as well as physiological abnormalities in the tubule (Terhzaz et al., 2010). The combination of developmental delay and bang sensitivity is shared with other Drosophila mutants that exhibit perturbed mitochondrial OXPHOS, including alleles of knockdown (kdn), which encodes citrate synthase (Fergestad et al., 2006), and technical knockout (tko25t), which encodes mitoribosomal protein S12 (Royden et al., 1987; Shah et al., 1997; Toivonen et al., 2001). A further bang-sensitive mutant in the gene easily shocked, which encodes ethanolamine kinase (Pavlidis et al., 1994), shares the phenotype of decreased steady-state ATP levels with sesB1, tko25t and some alleles of kdn (Fergestad et al., 2006) and might also act mitochondrially. tko25t manifests multiple deficiencies of the respiratory chain and OXPHOS, and exhibits an impaired response to sound and defective male courtship (Toivonen et al., 2001).

Importantly, when the human and Drosophila sequences are aligned, point mutation L289F in sesB1, a hydrophobic substitution in the final transmembrane-spanning helix of the protein (Pebay-Peyroula et al., 2003), is adjacent to the site of the hydrophobic substitution V298M in adPEO (Fig. 1A). Although the sesB1 phenotype differs in its tissue specificity from that of human ANT1-associated diseases, it presents a more disease-relevant genotype than the Ant1-knockout mouse, and is effectively free of the effects that are attributable to genetic redundancy. It therefore offers a convenient tool for understanding the metabolic and cellular consequences of ANT1 deficiency, and for testing strategies to compensate for pathological defects.

Fig. 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 1.

Genotype and phenotype of sesB1 flies. (A) Aligned partial sequences of sesB mRNA, isoform A (sesB+), commencing at nucleotide 962 of NCBI database entry NM_078554, and human ANT1 mRNA (NCBI database entry NM_001151 from nucleotide 863). The corresponding amino acid sequences and the base substitutions (red) and corresponding amino acid changes in the sesB1 allele, verified in the strain analyzed here, are also shown. The ANT1 gene mutation shown here is that reported in an Italian family with adPEO (Kaukonen et al., 2000). Each mutation results in the substitution of a hydrophobic residue in transmembrane segment VI of the protein (Pebray-Peyroula et al., 2003) by another hydrophobic residue. (B) The day of eclosion of flies of the genotypes indicated; means±s.e.m. are shown from five replicate vials. FM7 is the X-chromosomal balancer chromosome used to maintain heterozygosity for sesB1. (C) The square-root of the time taken to recover from mechanical shock (‘bang sensitivity’) for batches of ≥25 flies of each sex and genotype that were individually analyzed; means±s.e.m. are shown. The day of eclosion and bang sensitivity of sesB1 flies were significantly different from those of wild-type (wt) or heterozygous flies of the same sex (P<0.01). (D) Response of adult males of the indicated strains to sound. The mean number of responders±s.d. amongst groups of six males from three replicate groups of each genotype are shown. Bang-sensitive strains are: tko25t, point mutant of technical knockout, which encodes mitoribosomal protein S12 (Shah et al., 1997); bss, bang senseless, a point mutant of paralytic, which encodes a voltage-gated Na+ channel (Parker et al., 2011); sesB1; and sda, slamdance, which encodes aminopeptidase N (Zhang et al., 2002). tko25t, sesB1 and sda are non-responsive, whereas bss has normal hearing. (E) Lifespan curves for sesB1 and wild-type control flies of the sexes indicated (groups of 100 flies of each sex and genotype) when maintained at 25°C. Three replicate experiments gave similar results – i.e. mean lifespans of 11–13 days for sesB1 males and 13–18 days for sesB1 females. (F) GFP that was targeted to the mitochondria was expressed in indirect flight muscles of wild-type and sesB1 flies (in both genotypes in the presence of a transgene encoding UAS-mito-HA-GFP and the Mef2-GAL4 driver). The mitochondrial network appears normal in sesB1. (G) Dark-field micrograph of the dissected ovaries from 2-day-old wild-type and sesB1 females. (H) Phase-contrast micrograph of developing embryos from eggs laid by sesB1 females. The vast majority of embryos failed to hatch, and only a tiny number (~0.1%) completed development.

In previous studies, we used transcriptomic analysis to profile changes in gene expression in the tko25t mutant compared with wild-type flies. The results implied that there is a metabolic shift in tko25t flies, with diversion of pyruvate to lactate to regenerate NAD+, increased mobilization of dietary fat and protein, and the induction of anaplerotic pathways to maintain the flow of carbon skeletons for biosynthesis (Fernández-Ayala et al., 2010). We have also shown that the tko25t phenotype can be partially suppressed by additional dosage of the mutant gene (Kemppainen et al., 2009) or by altering mtDNA background (Chen et al., 2012), which appeared to act by increasing mitochondrial biogenesis. Therefore, we aimed to analyze metabolism and gene expression in sesB1 flies and to test different strategies to compensate the mutant phenotype, using similar approaches as those used previously for tko25t.

Because the sesB1 and tko25t phenotypes overlap, transcriptomic analysis can address what underlies the differences and similarities between the two mutants at the molecular level. These two classes of mutant – i.e. the one affecting mitochondrial protein synthesis, the other affecting intracellular nucleotide transport and synthesis – are common causes of mitochondrial disease (Saada, 2004; Sharer, 2005; Jacobs and Turnbull, 2005). Therefore, understanding both the common and the specific features of their molecular pathology should lead to more accurate diagnosis and targeted therapy.

In the mouse, transcriptomic studies have, thus far, been reported only in the skeletal muscle of 9- to 12-month-old animals for a limited set of known mitochondrially targeted gene products (Subramaniam et al., 2008), providing evidence of a paradoxical or futile upregulation of mitochondrial biogenesis. Here, we extend this to a more comprehensive analysis involving the whole genome and the whole organism in the Drosophila melanogaster model.

RESULTS

Strain verification and phenotyping

In order to analyze metabolism and gene expression in sesB1 mutant flies, and to test possible strategies for suppressing the mutant phenotype, we first verified the genotype (Fig. 1A) and phenotype (Fig. 1B–H) of the available strain, which was further backcrossed into standard wild-type backgrounds (Oregon R and Canton S). Compared with tko25t (Chen et al., 2012; Kemppainen et al., 2009), the developmental delay of sesB1 was less pronounced, notably in males (Fig. 1B), whereas the bang sensitivity of sesB1 adults, when tested at 3 days of age, was greater (Fig. 1C). sesB1 flies were also deaf (Fig. 1D), as judged by a behavioral assay for response to sound, as used previously to study tko25t flies (Toivonen et al., 2001). Despite the short lifespan (Fig. 1E), the muscle mitochondrial network in young adult flies was intact (Fig. 1F), unlike that seen in the case of other degenerative mutations that affect mitochondrial functions, such as Pink15 (Deng et al., 2008). Female flies were essentially sterile. At 2 days of age, ovary size was, typically, decreased (Fig. 1G), although eggs were eventually produced in normal, or near normal, numbers. However, eggs that were laid developed only as far as the late-embryo stage (Fig. 1H), with a tiny number of survivors reaching adulthood (~0.1% of the number of progeny from control crosses). Males were fertile but, in courtship assays, they displayed a defect similar to that observed previously for tko25t (Toivonen et al., 2001): in two separate experiments, only one of 11 and one of 13 individual sesB1 males reached copulation with single wild-type females, whereas ten out of ten wild-type males successfully copulated.

sesB1 flies have defects in respiration and OXPHOS

In order to test how the sesB1 mutation affects the properties of the ANT protein, we measured the rate of respiration of isolated mitochondria from sesB1 and control flies in the presence of different substrates, with and without the addition of 1 mM ADP. The respiratory control ratio (RCR), computed as the respiration rate in the presence of ADP divided by that in its absence, represents the degree to which respiration is limited by ATP synthesis, which is in turn dependent on ANT activity. On both complex-I- and complex-III-linked substrate mixes, mitochondria from sesB1 flies showed a significant drop in the apparent RCR (Table 1; Fig. 2A), consistent with decreased ANT activity limiting both ATP synthesis and respiration. Note, however, that because of the secondary activation of isocitrate dehydrogenase by ADP, the complex-I-linked data is not a true reflection of the RCR (Miwa et al., 2003). There was a 50% decrease in RCR, even using the complex-III-linked substrate glycerol-3-phosphate.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 1.

Oxygen consumption of isolated mitochondria from sesB1 and control flies on different substrates

Fig. 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 2.

Mitochondrial metabolism in sesB1 flies. (A) Apparent respiratory control ratio (RCR; the relative rate of oxygen consumption before and after the addition of ADP) of isolated mitochondria from flies of the strains and sexes indicated, using different substrate mixes, based on the data shown in Table 1. Note that the value obtained with the pyruvate and proline substrate mix is not a true RCR, because of the secondary activation of isocitrate dehydrogenase by ADP (Miwa et al., 2003). However, a similar trend is observed with both substrate mixes. (B) Steady-state ATP levels in the extracts from flies of the strains and sexes indicated, normalized to the value in wild-type (wt) flies in the given sex. The means of results from five or six biological replicates for each group are shown. (C) Steady-state lactate levels in extracts from 10-day-old flies of strains and sexes indicated. n=6 for males, n=3 for females. (A–C) Means±s.d., *P<0.05, **P<0.01 by using Student’s t-test. (D) Representative blue native electrophoresis gels, which were stained histochemically for complex I and IV, of extracts from flies of the strains and sexes indicated. Arrows indicate the major complexes that were stained; their apparent molecular weights were extrapolated from the migration of markers.

Steady-state ATP levels were also consistently lower in sesB1 flies than control flies (Fig. 2B). Under conditions where respiration is limiting, re-oxidation of NADH should depend on cytosolic enzymes, such as lactate dehydrogenase. This was reflected here by increased levels of lactate (Fig. 2C). In order to investigate the effects of the sesB1 mutation on the respiratory chain, we analyzed the activity of complex I and IV in mitochondrial extracts from sesB1 and control flies, using blue-native electrophoresis (BNE) combined with histochemical staining (Fig. 2D; supplementary material Fig. S1). Complex I activity in sesB1 was indistinguishable from that in wild-type flies, but there was a clear decrease in complex IV activity, especially in females.

Changes in gene expression in sesB1 are partly sex-specific

We implemented a gene expression analysis of sesB1 flies using procedures identical to those used previously to analyze tko25t. To minimize strain-specific effects, the flies analyzed using the Affymetrix Drosophila 2.0 microarray were, as in the case of tko25t, an F1 hybrid of sesB1 that had been backcrossed to Canton S or Oregon R backgrounds, and the results were compared with those of a corresponding control F1. The changes in the expression of a subset of genes were then verified by quantitative RT-PCR (Table 2). Analyses were conducted separately for males and females, in order to clarify the bisexual versus sex-specific aspects of the mutant phenotype.

View this table:
  • View inline
  • View popup
  • Download powerpoint
Table 2.

Verification of microarray data by quantitative RT-PCR

After statistical filtering, we identified 903 probesets that detected genes whose expression in sesB1 females differed at least twofold from that of wild-type controls (supplementary material Table S1), and 366 such probesets in males (supplementary material Table S2). Only 181 probesets were shared between the sexes (Fig. 3A; supplementary material Table S3), 177 of which showed directionally congruent changes, most of which were quantitatively very similar, with eight times as many genes that were upregulated as downregulated. Gene ontology (GO) analysis revealed that the genes represented by the 181 bisexually-regulated probesets were mostly annotated with molecular functions in metabolism (Fig. 3E). Of the probesets that were regulated in a sex-specific manner, downregulation was slightly more prevalent than upregulation. We inspected in more detail the expression patterns and GO terms of the 20 most up- or downregulated sex-specific annotated genes in each sex (Table 3), which revealed a consistent pattern. The sex-specific upregulated genes fell mostly into similar categories as those regulated bisexually, suggesting that these represent pathways regulated in a similar way in the two sexes, but in which specific genes were rejected in one sex. This might have been due to the stringent statistical filtering, or, alternatively, to the quantitative limitations of the method, in comparison with quantitative PCR (see Table 2). Some of the genes that were specifically downregulated in males were also in these categories. However, the remaining genes that were downregulated in males, and almost all of those that were downregulated in females, were associated with reproduction and broadly consistent with the organismal phenotype. Thus, the genes that were most downregulated in females were predominantly involved in oogenesis – including chorion formation and cell division functions – which is consistent with defective oocyte development. In males, the most prominent set of sex-specific downregulated genes were expressed primarily, or exclusively, in the accessory glands and have been implicated in pheromone perception and other aspects of courtship behavior, in which sesB1 males were defective. Global GO analysis of the annotated genes that showed alterations in their expression in a sex-specific manner in sesB1 flies (supplementary material Tables S4, S5) was consistent with this ‘top 20’ analysis, although many ovary-specific or ovary-enriched genes that are involved in oogenesis are listed under other categories – such as anatomical structure development, cell cycle, cell differentiation, cell division, chromosome or cytoskeleton organization, mitosis, chromosome segregation or DNA metabolic process.

Fig. 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 3.

Summary of transcriptomic analysis of sesB1 flies. (A–D) Diagrammatic representation of degree of overlap between probesets that had altered expression from wild type; fly strains and sexes are indicated. For details, see supplementary material Tables S1–S7. (E) GO classification by molecular function of the genes that showed altered expression in sesB1 flies of both sexes (panel A; supplementary material Table S1).

View this table:
  • View inline
  • View popup
Table 3.

Genes most highly regulated in sesB1 in a sex-specific manner

Changes in gene expression in sesB1 flies overlap those in tko25t

Next, we compared the patterns of change in gene expression in sesB1 flies with those seen in tko25t (Fig. 3B–D; supplementary material Tables S6–S10) in order to reveal both common and distinct pathways that are affected in these models of two major classes of mitochondrial disease. For coherence with the previous analysis of tko25t (Fernández-Ayala et al., 2010), we applied a slightly more relaxed criterion of a statistically robust expression difference of ≥1.5-fold. In males, approximately two-thirds of the probesets that showed altered expression in tko25t were also altered in sesB1, and half of the genes that showed altered expression in sesB1 were also altered in tko25t with, once again, all but a handful of genes showing the same directional difference in their expression, most of which were quantitatively very similar (Fig. 3B; supplementary material Table S7). In females, the vast majority of the probesets that showed altered expression in tko25t were also altered in sesB1 flies (383 of 473 probesets), whereas a larger number of the genes that showed altered expression in sesB1 females (611 probesets) did not appear in the tko25t list (Fig. 3C; supplementary material Table S6). Almost all of the genes that showed the greatest changes in expression in tko25t flies, whether regulated bisexually or in a sex-specific manner, were altered to a similar degree in sesB1 (supplementary material Table S10). Of those showing the greatest sex-specific changes in sesB1 females, as listed in Table 2, 15 out of 20 of those that were upregulated were also upregulated in tko25t, whereas only seven out of the 20 most downregulated genes in sesB1 females were also downregulated in tko25t females. Considering both mutant backgrounds, 126 probesets were regulated in a similar manner in both sexes in both mutant strains (Fig. 3D; supplementary material Table S8), whereas a larger number were sex-specific (Fig. 3D; supplementary material Table S9). GO analysis of the genes that were up- or downregulated in sesB1 females but not in tko25t females placed these genes in diverse categories. However, more than half of the 122 annotated genes that were downregulated (but almost none of the upregulated genes) are expressed uniquely, or predominantly, in the female reproductive system (www.flyatlas.org).

Altered expression of metabolic genes in sesB1 reflects the biochemical phenotype

The observed changes in the expression of metabolic genes in sesB1 can be broadly rationalized, as in the case of tko25t, in the following manner. First, the bulk of ATP production is shifted to glycolysis, with conversion of pyruvate to lactate to regenerate NAD+. Second, fatty acids and amino acids are mobilized, and anaplerotic pathways induced to maintain the flow of carbon skeletons for biosynthesis. Thus, there was upregulation of a set of enzymes that converged on pyruvate and acetyl-CoA in both sexes – fructose-1,6-bisphosphatase, aldolase, phosphoenolpyruvate carboxykinase (Pepck), lactate dehydrogenase, acetyl-CoA synthetase and aldehyde dehydrogenase, as well as alcohol dehydrogenase in females (supplementary material Table S11). A second Pepck isogene (CG10924) and a testis-specific lactate dehydrogenase gene were downregulated (in males). There was also an overlap between the sets of genes that showed altered expression in sesB1 and those that are altered under starvation (Farhadian et al., 2012), although some of the changes were in opposite directions (supplementary material Table S12).

Testing for phenotypic complementation of sesB1 by altered mtDNA background or spargel overexpression

In previous work, we have described the partial alleviation of the phenotypes of Drosophila mutants that represented mitochondrial disease models associated with cytochrome oxidase deficiency (Fernández-Ayala et al., 2009; Kemppainen et al., 2014), complex I deficiency (Sanz et al., 2010a), DNA polymerase γ disease (Humphrey et al., 2012) and disorders of mitochondrial protein synthesis (Kemppainen et al., 2009; Chen et al., 2012). The similar organismal phenotypes and the overlapping patterns of altered gene expression in tko25t and sesB1 led us to question whether the same strategies might be effective in sesB1 flies.

We have previously reported that the BER-1 mtDNA background, which produced a clear phenotypic improvement in tko25t, had no effect on the developmental phenotype of sesB1, although there was a partial rescue of its short lifespan (Chen et al., 2012). Note, however, that observations of eclosion timing and bang sensitivity that we reported in that publication were made after backcrossing sesB1 directly into the BER-1 cytoplasmic background, which remained infected with the endosymbiont Wolbachia. Furthermore, the continued presence of Wolbachia compromised the increase in the lifespan of sesB1 that was conferred by the BER-1 mtDNA background (see figure 3 in the supplementary data of Chen et al., 2012). Therefore, we investigated whether the BER-1 mtDNA background, in the absence of Wolbachia, was able to rescue the developmental phenotype of sesB1.

BER-1 females, after removal of Wolbachia by tetracycline treatment (Dobson et al., 2002; Chen et al., 2012), were backcrossed for more than five generations to sesB1 in order to create a cybrid strain that contained BER-1 mtDNA but the original nuclear genome of sesB1. Phenotypic testing of the cybrid flies indicated a partial rescue of both developmental delay (Fig. 4A) and bang sensitivity (Fig. 4C). In previous work, we found that the partial rescue of tko25t by the BER-1 mtDNA background was accompanied by an increased expression level of the Drosophila PGC-1α homolog spargel (Chen et al., 2012) and, furthermore, that overexpression of spargel was able to phenocopy the effect. However, in the sesB1 flies we did not find any effect of the BER-1 mtDNA background on the expression level of spargel (Fig. 4D), indicating that this is not the mechanism of rescue.

Fig. 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 4.

Testing rescue of sesB1 by altered mtDNA background or spargel overexpression. (A,B) The day of eclosion of flies of the genotypes and sexes indicated is shown; means±s.d. from three replicate experiments. FM7 is the X-chromosomal balancer chromosome used to maintain heterozygosity for sesB1, which gives a wild-type phenotype. BER-1;sesB1 denotes cybrid flies (BER-1 mtDNA, sesB1 mutation and nuclear background). srlGR (an additional genomic copy of spargel) was homozygous, as indicated. (C) The square-root of the recovery time from mechanical shock (bang sensitivity) of flies of the genotypes and sexes indicated; means±s.e.m. are shown. srlGR flies in this experiment were hemizygous. The number of individually analyzed flies of each genotype was between 19 and 24 for the different classes. In B and C, #P<0.05, *P<0.01 between sesB1 and other data classes. Note that t-test or ANOVA cannot be meaningfully implemented for A owing to the skewed distribution of the day of eclosion in the BER-1 mtDNA background; hence the data are only indicative. The partial rescue of bang sensitivity by overexpression of spargel is statistically significant, but because an entire chromosome is replaced in this experiment, we cannot exclude a contribution of the genetic background. (D) Relative spargel mRNA levels, in flies of the sex and genotype indicated, normalized to the value in the same sex for wild-type flies. Only the lines that overexpressed spargel showed a significant increase in the mRNA, denoted by *, as above. (E) The mean proportion of eggs that developed into adults for the offspring of females, of the genotypes indicated, mated to wild-type males. Means±s.d. from three replicate experiments are shown.

We also tested directly whether spargel overexpression was able to suppress the sesB1 phenotype. Despite an apparent partial rescue of bang sensitivity (Fig. 4C), there was no rescue of developmental delay (Fig. 4B), despite the increase in spargel expression at the RNA level that was conferred by the extra copy of the gene (Fig. 4D). spargel overexpression produced only a minimal rescue of the sterility of sesB1 females when mated to wild-type males (Fig. 4D), which was also the case for the BER-1 flies, with only a slight increase in the number of survivors as compared with that resulting from control crosses.

Phenotypic complementation of sesB1 by AOX expression

Use of a respiratory chain bypass for complexes III and IV, via the alternative oxidase (AOX) from the sea squirt Ciona intestinalis, should facilitate electron flow through complex I, if the latter is inhibited by a limitation on ATP synthesis imposed by ANT dysfunction. This is predictable from the fact that complex I, combined with AOX, pumps fewer protons per electron than the regular respiratory chain. Any additional restriction due to a decrease in complex IV activity (Fig. 2D) might also be circumvented. Furthermore, respiration through complex II or other dehydrogenases that donate electrons to ubiquinone should also be facilitated under such conditions, because, when combined with AOX, they do not pump any protons. Thus, AOX expression should relieve sesB1 phenotypes that result from disturbed redox or metabolic homeostasis, but not those caused by decreased ATP synthesis per se.

Testing showed that AOX expression was unable to rescue developmental delay (Fig. 5A), although there was, once again, a minor degree of rescue of bang sensitivity (Fig. 5B), which was not further enhanced by da-GAL4-driven high-level expression. Expression of the alternative mitochondrial NADH dehydrogenase Ndi1 from yeast (Fig. 6A) was also unable to rescue developmental delay and, instead, tended to increase it.

Fig. 5.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 5.

Partial rescue of sesB1 by AOX expression. (A) The day of eclosion of flies of the genotypes and sexes indicated, reared at 22°C. Where present, da-GAL4 and UAS-AOX transgenes were hemizygous. ** significant differences between sesB1 and other data classes (P<0.01). The means±s.d. from eight to 14 replicate experiments are shown. (B) Bang sensitivity – the square-root of recovery time from mechanical shock of 3-day-old flies of the genotypes and sexes indicated, reared at 22°C; means±s.e.m. are shown. 79–215 flies of each class were analyzed individually. **P<0.01 between data classes for each sex (calculated by Student’s t-test with Bonferroni correction). (C) Mean numbers of offspring per vial as a result of mating females of the indicated genotypes (reared at 22°C) with wild-type (Oregon R) males. +, hemizygous; ++, homozygous; −, absence of a given marker, balancer or transgene. *P<0.05, **P<0.01 between sesB1;AOX and other data classes for each sex (Student’s t-test). (D) Lifespan curves for male flies of the indicated genotypes. Canton S (CS) and Oregon R (OR) are different strain backgrounds, which show curtailed lifespans similar to that of sesB1. Where present together, da-GAL4 and UAS-AOX transgenes were hemizygous. When UAS-AOX alone was present, it was homozygous in order to control for the number of copies of the mini-white selectable marker. The survival curve for AOX-expressing males is significantly different from all of the control lines, including sesB1 in either genetic background (log-rank test, P<0.001). However, given that the increase in mean lifespan was quantitatively minor, and was not seen in females, a contribution from the genetic background cannot be excluded.

Fig. 6.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig. 6.

Lack of rescue of sesB1 by Ndi1 expression. (A) The day of eclosion of flies of the genotypes and sexes indicated; means±s.e.m. from three biological replicates are shown. Where present, da-GAL4 and UAS-Ndi1 transgenes were hemizygous. **P<0.01 between sesB1;Ndi1 and other data classes for each sex (Student’s t-test with Bonferroni correction where appropriate). (B) The mean numbers of offspring per vial resulting from the mating of females of the genotypes indicated with wild-type (Oregon R) males. +, hemizygous; ++, homozygous; −, absence of a given marker, balancer or transgene.

To test for the possible rescue of female sterility, we crossed sesB1 females (1- to 4-day-old virgins) that also carried transgenic upstream activator sequence (UAS)-AOX (Fernández-Ayala et al., 2009), with or without the ubiquitously acting da-GAL4 driver, with wild-type males. Control females that were heterozygous for sesB1 gave substantial numbers of progeny (Fig. 5C), but, unlike non-transgenic sesB1 homozygous females or the flies that had been tested previously in the BER-1 mitochondrial or spargel overexpressor backgrounds, those flies also endowed with UAS-AOX gave progeny well in excess of the ~0.1% survivor rate obtained routinely from sesB1 females. In the presence of only the transgene encoding UAS-AOX, the number of progeny was ~3% of the number from control crosses, but the additional presence of the da-GAL4 driver raised this to 15–20% (Fig. 5C). Ndi1 expression failed to rescue female sterility, with only a tiny number of progeny (Fig. 6B). Note that the experiments using the transgenes that encoded UAS-AOX and UAS-Ndi1 were performed in the same genetic background, thus the differences are biologically meaningful, as well as statistically significant.

The short lifespan of sesB1 flies was marginally improved by AOX expression – AOX-expressing males showed a statistically significant increase in their mean lifespan of 3–4 days compared with that of control groups (Fig. 5D), but the effect in females was negligible (Fig. 6B). However, given that the rescue was quantitatively minor and sex-specific, a contribution of the genetic background cannot be excluded.

DISCUSSION

In this study, we characterized the biochemical and phenotypic consequences of the sesB1 mutation in the major ANT gene of Drosophila, and tested different strategies to complement its phenotype in vivo. We determined that the mutation limits respiration, causes a moderate deficiency of ATP and increases the level of lactate. Most aspects of the adult phenotype, and alterations in gene expression that affect metabolism, are shared with the tko25t mutant, revealing common underlying molecular pathways. However, sesB1 flies also exhibit the distinct, and sex-specific, phenotype of female sterility, which is associated with a downregulation of a broad range of genes that are associated with oogenesis. Female sterility was overcome by the expression of AOX from Ciona, but this did not rescue developmental delay and only partially alleviated bang sensitivity. Crossing sesB1 into the BER-1 mtDNA background produced modest apparent improvements in the developmental phenotype but had little impact on female fertility, whereas the effects of spargel overexpression were even more minor.

Implications of the biochemical phenotype

The sesB1 biochemical phenotype is the same as that which would be predicted if the mutation causes a decreased rate of adenine nucleotide exchange. The RCR can be construed as reflecting the degree of functional coupling between ATP synthesis and respiratory electron flow. A low RCR (Fig. 1A), combined with ATP deficiency (Fergestad et al., 2006; Terhzaz et al., 2010), as verified here (Fig. 1B), thus reflects either increased proton leak across the inner mitochondrial membrane and/or a limitation on ATP synthesis, either of which are plausible molecular consequences of the sesB1 mutation, which affects the final transmembrane segment of the protein. Despite modeling in yeast, which supported uncoupling as the mechanism of adPEO mutations in ANT1 (Wang et al., 2008), we favor the latter explanation because it is more easily reconciled with the fact that the mutation is recessive and is parsimonious with the reported biochemical phenotype of the V298M adPEO mutation (Kawamata et al., 2011), which affects the residue adjacent to that mutated in sesB1. Previously, it was shown that decreased expression of wild-type sesB decreased the net proton conductance of the inner mitochondrial membrane, whereas its overexpression increased it (Brand et al., 2005). Thus, increased proton leak seems an unlikely explanation for the effect of the sesB1 mutation. Furthermore, the apparent decrease in the amount of functional cytochrome oxidase (Fig. 1D) is a plausible response to a limitation of ATP synthesis as a mechanism to restrict electron flow and prevent increased membrane potential that would result in overproduction of ROS, as seen in the mouse Ant1 knockout (Esposito et al., 1999). Increased proton leak would be expected to produce, if anything, an opposite response to that observed here.

Based on the findings from transcriptomics and metabolite analysis, we found evidence of a remodeling of metabolism that should favor glycolytic ATP generation – pyruvate was converted to lactate to regenerate NAD+, fatty acid and amino acid mobilization and catabolism were induced, as well as the induction of anaplerotic pathways to compensate for a presumed decrease in the mitochondrial import of pyruvate. Furthermore, the major stress-response gene, Hsp22, a mitochondrial chaperone of the lens-crystallin superfamily, was upregulated (Morrow et al., 2000; Michaud et al., 2002). As a programmed response to transient mitochondrial insufficiency, we hypothesize that this is sufficient to sustain metabolism and support development, even if the outcome is sub-optimal, yielding flies that are bang-sensitive and defective in reproduction.

Phenotypic overlap with tko25t

The sesB1 phenotype has many similarities with that of tko25t, including decreased ATP levels, developmental delay, bang sensitivity, male courtship defect, hearing impairment and a similar remodeling of the metabolic component of gene expression (Toivonen et al., 2001; Fernández-Ayala et al., 2010; Chen et al., 2012). When considering potential future treatments of these distinct classes of mitochondrial disease, such common molecular pathways might prove fruitful targets.

One major difference between the two mutants is that tko25t has an essentially normal lifespan (Chen et al., 2012), whereas that of sesB1 is drastically shortened (Fig. 1D). The adult fly is essentially post-mitotic; therefore, in contrast with development – when active cell growth and cell division take place – mitochondrial protein synthesis in adults is required only to keep pace with protein and organelle turnover. A greatly decreased capacity for mitochondrial protein synthesis, as in tko25t, might thus have severe effects on development, yet still be above the rate that is required for turnover in the adult. If this is the case, the capacity for OXPHOS should gradually increase in tko25t adults, eventually reaching a level similar to that of wild-type flies, with only a minimal, and probably undetectable, effect on aging.

By contrast, the limitation on respiration and OXPHOS that is conferred by decreased ANT activity in sesB1 should persist in the adult, imposing chronic stress and probably accounting for the drastically curtailed lifespan. One obvious potential stressor that is already associated both with ANT dysfunction and lifespan regulation is excess ROS production. AOX decreases mitochondrial ROS production, even under non-inhibited conditions (Fernández-Ayala et al., 2009; Sanz et al., 2010b), although this is not understood mechanistically. The modest lifespan extension that is produced by AOX, at least in sesB1 males, could thus be mediated through an effect on ROS. However, this increase is quantitatively too small to exclude an effect of genetic background.

A second major difference between sesB1 and tko25t is that tko25t females are fertile, despite a reduced rate of egg laying (Fernández-Ayala et al., 2010), whereas sesB1 females are sterile, giving rise to eggs that can be fertilized but fail to complete embryogenesis. This is also reflected in decreased ovary size (Fig. 1G) and the downregulation of many genes that are connected with oogenesis in sesB1 females (Table 3; supplementary material Table S5). Although the number of survivors was slightly increased in the BER-1 mtDNA background or upon increased spargel expression, only the expression of AOX, driven by da-GAL4, was able to produce a pronounced rescue. By contrast, expression of Ndi1, which bypasses (and also alleviates ROS production at) complex I (Sanz et al., 2010a), had only a negligible effect on female sterility (and lifespan), excluding background effects from the da-GAL4 driver or the w1118 recipient that was used to generate the transgenic lines. AOX was partially effective at alleviating female sterility, even when expressed only at a low level (without the da-GAL4 driver), which was also the case for its partial rescue of bang sensitivity, reminiscent of previous observations on its rescue of the locomotor defect that is caused by deficiency of dj-1β (Fernández-Ayala et al., 2009).

The fact that AOX partially rescued fertility, whereas Ndi1 did not, can be interpreted in several alternative ways. The first possibility is that rescue by AOX involves the mobilization of substrates that supply electrons downstream of complex I (such as succinate or glycerol-3-phosphate). AOX can transfer these electrons to oxygen without net proton pumping, circumventing the limitation on electron flow that is imposed by the coupling mechanism caused by ANT insufficiency. The second is that the observed downregulation of complex IV in sesB1 flies limits any facilitation of electron flow by Ndi1. AOX bypasses complex IV and so should be unaffected. The third possibility invokes a different metabolic effect of AOX, such as decreased ROS production.

Because the standard UAS-GAL4 system is inactive in the female germline (Rørth, 1998), the AOX-mediated rescue of sterility must be attributable to its expression in somatic tissues, or in the embryo itself. Because sesB1 females are sterile when mated to wild-type males, it is evident that zygotic expression of even sesB itself cannot rescue sterility. Thus, it seems unlikely that AOX could do so. Instead, we favor the idea that insufficiency of mitochondrial adenine nucleotide transport in one or more somatic cell types in the ovary leads to a dysregulation of oogenesis that can be rescued by AOX. The fact that so many ovary-specific genes are downregulated in sesB1 is consistent with a general failure of oogenesis rather than a specific metabolic abnormality in developing oocytes.

The somatic cells of the ovary, in particular the follicle cells, play key roles in the patterning of the developing oocyte (Deng and Bownes, 1998; Poulton and Deng, 2007), and many molecular signaling pathways are involved (Roth et al., 1995; Neuman-Silberberg and Schüpbach, 1996; Rørth et al., 2000; Yamamoto et al., 2007; Stein et al., 2013; Fregoso Lomas et al., 2013), some of which are functionally conserved in vertebrates (Charlier et al., 2012). Moreover, cell proliferation and migration – crucial to the developmental function of the follicular epithelium – are commonly regulated by metabolite or redox signaling (Veal and Day, 2011; Hurd et al., 2012). ANT dysfunction might interfere with this signaling, whereas AOX might restore it.

Modifiers of the sesB1 phenotype

ANT is an abundant component of the protein-rich inner mitochondrial membrane, probably reflecting a quantitative requirement for a high rate of adenine nucleotide transport to match the capacity of ATP synthase. For this reason, a decrease in ANT activity is likely to become limiting for ATP synthesis, with a small margin for compensation by increasing the expression or stabilization of the protein. However, globally increased mitochondrial biogenesis mediated by, for example, PGC-1α (spargel) would be a plausible compensation strategy. In previous studies, this pathway has been implicated in the partial rescue of tko25t by the BER-1 mtDNA background (Chen et al., 2012). However, the modest phenotypic improvement in sesB1 that was brought about by BER-1 mtDNA was not accompanied by increased spargel expression. Moreover, a twofold overexpression of spargel had no effect on the developmental delay of sesB1 flies, indicating that a different mechanism underlies the effects of BER-1-mediated rescue.

Compared with control strains, BER-1 mtDNA contains a number of sequence polymorphisms, which affect both protein- and RNA-encoding genes (Chen et al., 2012). These might act in a variety of ways to modify the sesB1 phenotype – e.g. by altering the functional properties of the OXPHOS system, the architecture of the inner mitochondrial membrane or the output of mitochondrial protein synthesis. An effect on mitochondrial biogenesis that is independent of the spargel pathway can also not be excluded. In order to understand how BER-1 influences sesB1 it will be useful to compare in detail the properties of isolated mitochondria from sesB1 and control flies containing BER-1 versus control-strain mtDNA. Regardless of the precise mechanism, our findings provide support for the idea that the mitochondrial genotype can act as a modifier in humans with recessive ANT1-linked disease (Strauss et al., 2013).

sesB1 as a disease model and implications for therapy

Despite its ability to rescue female sterility, AOX expression produced no improvement in the developmental delay of sesB1 flies, consistent with the notion that this phenotype is, most probably, attributable to the limitation on ATP production that is imposed by sesB1. ATP deficiency, specifically at synapses, has also been suggested to underlie the phenotype of a second mutant allele of sesB, sesBorg, which confers temperature-sensitive paralysis (Rikhy et al., 2003).

Overall, our findings indicate that there are at least two pathways by which ANT deficiency can lead to pathological tissue dysfunction, and the sesB1 model now allows these to be explored in further detail. The first pathway is through bioenergetic insufficiency, manifesting as an ATP deficit, of which developmental delay is the principal indication. Its apparent alleviation by the BER-1 mtDNA background might have substantial implications for therapy, if the mechanism can be elucidated. Conversely, despite a large interest in therapeutically boosting PGC1-α expression (Wenz et al., 2008; Srivastava et al., 2009; Dillon et al., 2012; Chaturvedi and Beal, 2013; Komen and Thorburn, 2014; Noe et al., 2013; Hofer et al., 2014), our results indicate that modulating PGC1-α activity might not be a viable strategy for alleviating the features of ANT1 diseases that are associated with bioenergy deficit. Nevertheless, much stronger activation of the pathway, such as using UAS-spargel, might yet be worth testing.

The second pathway by which ANT deficiency produces a pathological outcome is the one alleviated by AOX, involving disturbed metabolic or redox homeostasis.

Ubiquitous AOX expression in both the fly and the mouse is essentially benign (Fernández-Ayala et al., 2009; El-Khoury et al., 2013). The benefit of this in future therapy (El-Khoury et al., 2014) is already indicated by the ability of AOX to alleviate the pathological defects that are caused by functional loss of complex IV (Fernández-Ayala et al., 2009; Kemppainen et al., 2014) or other mitochondrial components that are needed for OXPHOS, such as DNA polymerase γ (Humphrey et al., 2012). Here, we extend this range of targets to include ANT, but with an important caveat. Clearly, only some of the phenotypes that are associated with pathological ANT dysfunction can be mitigated by AOX. Thus, any potential use of AOX in therapy for ANT-related, and other mitochondrial, disorders should be based on a clear understanding of the underlying pathological mechanism and the metabolic status. These might differ systematically between tissues, according to nutritional state or under influences of the genetic background.

MATERIALS AND METHODS

Flies, maintenance and behavioral assays

Drosophila melanogaster lines were as described previously (Toivonen et al., 2001; Fernández-Ayala et al., 2009; Sanz et al., 2010a; Kemppainen et al., 2009; Chen et al., 2012) or from stock centers (sesB1, bss, sda, Mef2-GAL4, mito-HA-GFP). The srlGR line (Tiefenböck et al., 2010), containing an additional genomic copy of the spargel gene, was a kind gift from Christian Frei (ETH Zürich, Switzerland). Flies were maintained at 25°C on standard medium with supplements, as described previously (Fernández-Ayala et al., 2009) except where indicated. Time to eclosion, bang sensitivity (at 25°C), response to sound and male courtship were measured as described previously (Toivonen et al., 2001). Lifespan at 25°C was determined as described previously (Sanz et al., 2010a).

Microscopy

The dissected ovaries from 2-day-old virgin females were placed on a slide in a droplet of PBS, and images were captured with and without coverslips by using a Nikon SMZ745T microscope with DS-Vi1 camera. The embryos were collected from mating chambers, dechorionated, placed on two-sided tape that was attached the bottom of a Petri dish and then minimally overlaid with dissection medium (137 mM NaCl, 5.4 mM KCl, 0.17 mM NaH2PO4, 0.22 mM KH2PO4, 33.3 mM glucose, 43.8 mM sucrose and 9.9 mM HEPES, pH 7.4). Embryos were imaged as described above. Indirect flight muscle mitochondria of flies that expressed GFP that was targeted to the mitochondria were imaged by using a Nikon Eclipse-Ti microscope (Nikon Instruments, Melville, NY) plus an Andor Neo sCMOS camera (Oxford Instruments, Abingdon, UK) with a 40× objective. The flies were grown for 2 days, after which the thoraxes were fixed with phosphate buffered 10% formalin pH 7.0 (FF-Chemicals, Haukipudas, Finland) for 30 minutes, washed with PBS three times for 10 minutes, after which further dissection of muscle fibers was performed with a 27-gauge needle attached to a 1 ml syringe.

Metabolite analysis

ATP levels were assayed using the ATP Determination Kit (Life Technologies, Carlsbad, CA) according to the manufacturer’s instructions. For each sample, a set of ten flies were homogenized in 100 μl of 6 M guanidine hydrochloride and then centrifuged at 12,000 gmax for 5 minutes at 4°C. Supernatants were diluted tenfold in TE buffer (10 mM Tris-HCl, 1 mM EDTA, pH 8.0), and 10 μl of the diluted sample was mixed with the reaction solution. Different genotypes were processed in biological triplicates and luminescence was measured using a Chameleon plate reader (Hidex, Turku, Finland).

Lactate was assayed by using a BioVision Lactate Colorimetric/Fluorometric Assay Kit (BioVision, Milpitas, CA) according to the manufacturer’s instructions. Samples of 30 flies per genotype were homogenized in 300 μl of lactate assay buffer and centrifuged at 12,000 gmax for 5 minutes at 4°C. Each genotype was analyzed in triplicate and sample fluorescence was recorded using the Hidex Chameleon plate reader.

Measurements of mitochondrial function

Mitochondria were isolated for oxygraphic analysis and blue native electrophoresis from ~200 flies per genotype, as previously described (Miwa et al., 2003). Protein concentrations were determined by the Bradford method (Bradford, 1976). Oxygen consumption of the isolated mitochondria was measured in a Clark-type electrode chamber (Hansatech Oxyterm system) in the presence of different substrate mixes (5 mM sodium pyruvate plus 5 mM proline for complex-I-linked respiration, 20 mM sn-glycerol 3-phosphate for complex-III-linked respiration) before and after the addition of 1 mM ADP, as described previously (Fernández-Ayala et al., 2009). The oxygen consumption in the presence of the different substrate mixes was then used to compute the RCR. Blue native electrophoresis and histochemical staining for complex I and IV activity were performed on mitochondrial extracts, as described previously (Sanz et al., 2010a).

RNA isolation and analysis

RNA extraction, microarray analysis using the GeneChip® Affymetrix Drosophila 2.0 array (Affymetrix, Santa Clara, CA) and quantitative RT-PCR were performed as described previously (Fernández-Ayala et al., 2009; Fernández-Ayala et al., 2010). RNA isolations were performed in triplicate from batches of 30 2-day-old males and virgin females. Raw microarray data was normalized and analyzed using Genespring GX software (Agilent Technologies, Santa Clara, CA). Previous raw data from tko25t mutant flies (Fernández-Ayala et al., 2010) was incorporated for comparative analysis, for which data normalization and analysis was performed afresh, grouping all values for the control samples. Genes that showed altered expression were clustered according to GO classes, using GO Term Mapper (Lewis-Sigler Institute for Integrative Genomics, Princeton University, NJ). For quantitative RT-PCR, cDNA was synthesized using the SuperScript® kit (Life Technologies, Carlsbad, CA) or, for spargel RNA, using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems). Analysis used a StepOnePlus instrument (Life Technologies, Carlsbad, CA) with the manufacturer’s SYBR® Green PCR reagents and customized primers, as listed in supplementary material Table S13. Normalization to RpL32 RNA was performed as described previously (Fernández-Ayala et al., 2009).

DNA extraction and sequencing

For sequencing, genomic DNA was prepared from batches of ten to 30 adult flies, as described previously (Fernández-Ayala et al., 2009). A 500 bp fragment of the sesB gene was amplified using primer pair sesB1F: 5′-GAGGAAGGAAGGGTTCTTGC-3′ and sesB1R: 5′-CATCGTGTCCTATCCCTTCG-3′. The purified PCR products were sequenced using the same primers (Life Technologies, 3130x1 Genetic Analyzer).

Statistical analysis

In all experiments, the means were compared, as appropriate, by Student’s t-test or ANOVA, with Bonferroni correction for multiple comparisons.

Acknowledgements

We thank Niels Krol for assistance with quantitative RT-PCR analyses, Eveliina Kaulio and Outi Kurronen for technical assistance, and Laurie Kaguni for useful discussions.

Footnotes

  • Competing interests

    The authors declare no competing financial interests.

  • Author contributions

    H.T.J., S.V., S.C. and K.M.C.O’D. conceived and designed the experiments, which were performed by S.C., S.V., T.T., J.G. and K.L. All authors contributed to data analysis. H.T.J. compiled the figures and tables, and drafted the manuscript.

  • Funding

    This work was supported by Academy of Finland (FinMIT Centre of Excellence, Academy Professorship to H.T.J., Academy postdoctoral fellowship to S.V.); Sigrid Juselius Foundation; Tampere University Hospital Medical Research Fund; the European Research Council (Advanced Grant 2326738 to H.T.J.); and the EU Marie Curie Programme (IOF 255472 to S.V.).

  • Supplementary material

    Supplementary material available online at http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.016527/-/DC1

  • Received April 10, 2014.
  • Accepted April 28, 2014.
  • © 2014. Published by The Company of Biologists Ltd

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.

References

  1. ↵
    1. Barca, E.,
    2. Aguennouz, M.,
    3. Mazzeo, A.,
    4. Messina, S.,
    5. Toscano, A.,
    6. Vita, G. L.,
    7. Portaro, S.,
    8. Parisi, D. and
    9. Rodolico, C.
    (2013). ANT1 is reduced in sporadic inclusion body myositis. Neurol. Sci. 34, 217–224.
    OpenUrlPubMed
  2. ↵
    1. Bradford, M. M.
    (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–254.
    OpenUrlCrossRefPubMedWeb of Science
  3. ↵
    1. Brand, M. D.,
    2. Pakay, J. L.,
    3. Ocloo, A.,
    4. Kokoszka, J.,
    5. Wallace, D. C.,
    6. Brookes, P. S. and
    7. Cornwall, E. J.
    (2005). The basal proton conductance of mitochondria depends on adenine nucleotide translocase content. Biochem. J. 392, 353–362.
    OpenUrlCrossRefPubMedWeb of Science
  4. ↵
    1. Charlier, C.,
    2. Montfort, J.,
    3. Chabrol, O.,
    4. Brisard, D.,
    5. Nguyen, T.,
    6. Le Cam, A.,
    7. Richard-Parpaillon, L.,
    8. Moreews, F.,
    9. Pontarotti, P.,
    10. Uzbekova, S.,
    11. et al.
    (2012). Oocyte-somatic cells interactions, lessons from evolution. BMC Genomics 13, 560.
    OpenUrlCrossRefPubMed
  5. ↵
    1. Chaturvedi, R. K. and
    2. Beal, M. F.
    (2013). Mitochondria targeted therapeutic approaches in Parkinson’s and Huntington’s diseases. Mol. Cell. Neurosci. 55, 101–114.
    OpenUrlCrossRefPubMed
  6. ↵
    1. Chen, S.,
    2. Oliveira, M. T.,
    3. Sanz, A.,
    4. Kemppainen, E.,
    5. Fukuoh, A.,
    6. Schlicht, B.,
    7. Kaguni, L. S. and
    8. Jacobs, H. T.
    (2012). A cytoplasmic suppressor of a nuclear mutation affecting mitochondrial functions in Drosophila. Genetics 192, 483–493.
    OpenUrlAbstract/FREE Full Text
  7. ↵
    1. Chevrollier, A.,
    2. Loiseau, D.,
    3. Reynier, P. and
    4. Stepien, G.
    (2011). Adenine nucleotide translocase 2 is a key mitochondrial protein in cancer metabolism. Biochim. Biophys. Acta 1807, 562–567.
    OpenUrlCrossRefPubMedWeb of Science
  8. ↵
    1. Deng, W. M. and
    2. Bownes, M.
    (1998). Patterning and morphogenesis of the follicle cell epithelium during Drosophila oogenesis. Int. J. Dev. Biol. 42, 541–552.
    OpenUrlPubMed
  9. ↵
    1. Deng, H.,
    2. Dodson, M. W.,
    3. Huang, H. and
    4. Guo, M.
    (2008). The Parkinson’s disease genes pink1 and parkin promote mitochondrial fission and/or inhibit fusion in Drosophila. Proc. Natl. Acad. Sci. USA 105, 14503–14508.
    OpenUrlAbstract/FREE Full Text
  10. ↵
    1. Deschauer, M.,
    2. Hudson, G.,
    3. Müller, T.,
    4. Taylor, R. W.,
    5. Chinnery, P. F. and
    6. Zierz, S.
    (2005). A novel ANT1 gene mutation with probable germline mosaicism in autosomal dominant progressive external ophthalmoplegia. Neuromuscul. Disord. 15, 311–315.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Dillon, L. M.,
    2. Williams, S. L.,
    3. Hida, A.,
    4. Peacock, J. D.,
    5. Prolla, T. A.,
    6. Lincoln, J. and
    7. Moraes, C. T.
    (2012). Increased mitochondrial biogenesis in muscle improves aging phenotypes in the mtDNA mutator mouse. Hum. Mol. Genet. 21, 2288–2297.
    OpenUrlAbstract/FREE Full Text
  12. ↵
    1. Dobson, S. L.,
    2. Marsland, E. J. and
    3. Rattanadechakul, W.
    (2002). Mutualistic Wolbachia infection in Aedes albopictus: accelerating cytoplasmic drive. Genetics 160, 1087–1094.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    1. El-Khoury, R.,
    2. Dufour, E.,
    3. Rak, M.,
    4. Ramanantsoa, N.,
    5. Grandchamp, N.,
    6. Csaba, Z.,
    7. Duvillié, B.,
    8. Bénit, P.,
    9. Gallego, J.,
    10. Gressens, P.,
    11. et al.
    (2013). Alternative oxidase expression in the mouse enables bypassing cytochrome c oxidase blockade and limits mitochondrial ROS overproduction. PLoS Genet. 9, e1003182.
    OpenUrlCrossRefPubMed
  14. ↵
    1. El-Khoury, R.,
    2. Kemppainen, K. K.,
    3. Dufour, E.,
    4. Szibor, M.,
    5. Jacobs, H. T. and
    6. Rustin, P.
    (2014). Engineering the alternative oxidase gene to better understand and counteract mitochondrial defects: state of the art and perspectives. Br. J. Pharmacol. 171, 2243–2249.
    OpenUrlCrossRefPubMed
  15. ↵
    1. Esposito, L. A.,
    2. Melov, S.,
    3. Panov, A.,
    4. Cottrell, B. A. and
    5. Wallace, D. C.
    (1999). Mitochondrial disease in mouse results in increased oxidative stress. Proc. Natl. Acad. Sci. USA 96, 4820–4825.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    1. Farhadian, S. F.,
    2. Suárez-Fariñas, M.,
    3. Cho, C. E.,
    4. Pellegrino, M. and
    5. Vosshall, L. B.
    (2012). Post-fasting olfactory, transcriptional, and feeding responses in Drosophila. Physiol. Behav. 105, 544–553.
    OpenUrlCrossRefPubMedWeb of Science
  17. ↵
    1. Fergestad, T.,
    2. Bostwick, B. and
    3. Ganetzky, B.
    (2006). Metabolic disruption in Drosophila bang-sensitive seizure mutants. Genetics 173, 1357–1364.
    OpenUrlAbstract/FREE Full Text
  18. ↵
    1. Fernández-Ayala, D. J.,
    2. Sanz, A.,
    3. Vartiainen, S.,
    4. Kemppainen, K. K.,
    5. Babusiak, M.,
    6. Mustalahti, E.,
    7. Costa, R.,
    8. Tuomela, T.,
    9. Zeviani, M.,
    10. Chung, J.,
    11. et al.
    (2009). Expression of the Ciona intestinalis alternative oxidase (AOX) in Drosophila complements defects in mitochondrial oxidative phosphorylation. Cell Metab. 9, 449–460.
    OpenUrlCrossRefPubMedWeb of Science
  19. ↵
    1. Fernández-Ayala, D. J.,
    2. Chen, S.,
    3. Kemppainen, E.,
    4. O’Dell, K. M. and
    5. Jacobs, H. T.
    (2010). Gene expression in a Drosophila model of mitochondrial disease. PLoS ONE 5, e8549.
    OpenUrlCrossRefPubMed
  20. ↵
    1. Fontanesi, F.,
    2. Palmieri, L.,
    3. Scarcia, P.,
    4. Lodi, T.,
    5. Donnini, C.,
    6. Limongelli, A.,
    7. Tiranti, V.,
    8. Zeviani, M.,
    9. Ferrero, I. and
    10. Viola, A. M.
    (2004). Mutations in AAC2, equivalent to human adPEO-associated ANT1 mutations, lead to defective oxidative phosphorylation in Saccharomyces cerevisiae and affect mitochondrial DNA stability. Hum. Mol. Genet. 13, 923–934.
    OpenUrlAbstract/FREE Full Text
  21. ↵
    1. Forlani, G.,
    2. Giarda, E.,
    3. Ala, U.,
    4. Di Cunto, F.,
    5. Salani, M.,
    6. Tupler, R.,
    7. Kilstrup-Nielsen, C. and
    8. Landsberger, N.
    (2010). The MeCP2/YY1 interaction regulates ANT1 expression at 4q35: novel hints for Rett syndrome pathogenesis. Hum. Mol. Genet. 19, 3114–3123.
    OpenUrlAbstract/FREE Full Text
  22. ↵
    1. Fregoso Lomas, M.,
    2. Hails, F.,
    3. Lachance, J. F. and
    4. Nilson, L. A.
    (2013). Response to the dorsal anterior gradient of EGFR signaling in Drosophila oogenesis is prepatterned by earlier posterior EGFR activation. Cell Rep. 4, 791–802.
    OpenUrlPubMed
  23. ↵
    1. Graham, B. H.,
    2. Waymire, K. G.,
    3. Cottrell, B.,
    4. Trounce, I. A.,
    5. MacGregor, G. R. and
    6. Wallace, D. C.
    (1997). A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator. Nat. Genet. 16, 226–234.
    OpenUrlCrossRefPubMedWeb of Science
  24. ↵
    1. Hofer, A.,
    2. Noe, N.,
    3. Tischner, C.,
    4. Kladt, N.,
    5. Lellek, V.,
    6. Schauß, A. and
    7. Wenz, T.
    (2014). Defining the action spectrum of potential PGC-1α activators on a mitochondrial and cellular level in vivo. Hum. Mol. Genet. 23, 2400–2415.
    OpenUrlAbstract/FREE Full Text
  25. ↵
    1. Humphrey, D. M.,
    2. Parsons, R. B.,
    3. Ludlow, Z. N.,
    4. Riemensperger, T.,
    5. Esposito, G.,
    6. Verstreken, P.,
    7. Jacobs, H. T.,
    8. Birman, S. and
    9. Hirth, F.
    (2012). Alternative oxidase rescues mitochondria-mediated dopaminergic cell loss in Drosophila. Hum. Mol. Genet. 21, 2698–2712.
    OpenUrlAbstract/FREE Full Text
  26. ↵
    1. Hurd, T. R.,
    2. DeGennaro, M. and
    3. Lehmann, R.
    (2012). Redox regulation of cell migration and adhesion. Trends Cell Biol. 22, 107–115.
    OpenUrlCrossRefPubMedWeb of Science
  27. ↵
    1. Jacobs, H. T. and
    2. Turnbull, D. M.
    (2005). Nuclear genes and mitochondrial translation: a new class of genetic disease. Trends Genet. 21, 312–314.
    OpenUrlCrossRefPubMedWeb of Science
  28. ↵
    1. Jordens, E. Z.,
    2. Palmieri, L.,
    3. Huizing, M.,
    4. van den Heuvel, L. P.,
    5. Sengers, R. C.,
    6. Dörner, A.,
    7. Ruitenbeek, W.,
    8. Trijbels, F. J.,
    9. Valsson, J.,
    10. Sigfusson, G.,
    11. et al.
    (2002). Adenine nucleotide translocator 1 deficiency associated with Sengers syndrome. Ann. Neurol. 52, 95–99.
    OpenUrlCrossRefPubMedWeb of Science
  29. ↵
    1. Kaukonen, J.,
    2. Juselius, J. K.,
    3. Tiranti, V.,
    4. Kyttälä, A.,
    5. Zeviani, M.,
    6. Comi, G. P.,
    7. Keränen, S.,
    8. Peltonen, L. and
    9. Suomalainen, A.
    (2000). Role of adenine nucleotide translocator 1 in mtDNA maintenance. Science 289, 782–785.
    OpenUrlAbstract/FREE Full Text
  30. ↵
    1. Kawamata, H.,
    2. Tiranti, V.,
    3. Magrané, J.,
    4. Chinopoulos, C. and
    5. Manfredi, G.
    (2011). adPEO mutations in ANT1 impair ADP-ATP translocation in muscle mitochondria. Hum. Mol. Genet. 20, 2964–2974.
    OpenUrlAbstract/FREE Full Text
  31. ↵
    1. Kemppainen, E.,
    2. Fernández-Ayala, D. J.,
    3. Galbraith, L. C.,
    4. O’Dell, K. M. and
    5. Jacobs, H. T.
    (2009). Phenotypic suppression of the Drosophila mitochondrial disease-like mutant tko(25t) by duplication of the mutant gene in its natural chromosomal context. Mitochondrion 9, 353–363.
    OpenUrlCrossRefPubMedWeb of Science
  32. ↵
    1. Kemppainen, K. K.,
    2. Rinne, J.,
    3. Sriram, A.,
    4. Lakanmaa, M.,
    5. Zeb, A.,
    6. Tuomela, T.,
    7. Popplestone, A.,
    8. Singh, S.,
    9. Sanz, A.,
    10. Rustin, P.,
    11. et al.
    (2014). Expression of alternative oxidase in Drosophila ameliorates diverse phenotypes due to cytochrome oxidase deficiency. Hum. Mol. Genet. 23, 2078–2093.
    OpenUrlAbstract/FREE Full Text
  33. ↵
    1. Komaki, H.,
    2. Fukazawa, T.,
    3. Houzen, H.,
    4. Yoshida, K.,
    5. Nonaka, I. and
    6. Goto, Y.
    (2002). A novel D104G mutation in the adenine nucleotide translocator 1 gene in autosomal dominant progressive external ophthalmoplegia patients with mitochondrial DNA with multiple deletions. Ann. Neurol. 51, 645–648.
    OpenUrlCrossRefPubMedWeb of Science
  34. ↵
    1. Komen, J. C. and
    2. Thorburn, D. R.
    (2014). Turn up the power – pharmacological activation of mitochondrial biogenesis in mouse models. Br. J. Pharmacol. 171, 1818–1836.
    OpenUrlPubMed
  35. ↵
    1. Lee, J.,
    2. Schriner, S. E. and
    3. Wallace, D. C.
    (2009). Adenine nucleotide translocator 1 deficiency increases resistance of mouse brain and neurons to excitotoxic insults. Biochim. Biophys. Acta 1787, 364–370.
    OpenUrlPubMed
  36. ↵
    1. Longley, M. J.,
    2. Clark, S.,
    3. Yu, Wai,
    4. Man, C.,
    5. Hudson, G.,
    6. Durham, S. E.,
    7. Taylor, R. W.,
    8. Nightingale, S.,
    9. Turnbull, D. M.,
    10. Copeland, W. C. and
    11. Chinnery, P. F.
    (2006). Mutant POLG2 disrupts DNA polymerase gamma subunits and causes progressive external ophthalmoplegia. Am. J. Hum. Genet. 78, 1026–1034.
    OpenUrlCrossRefPubMedWeb of Science
  37. ↵
    1. Mayr, J. A.,
    2. Haack, T. B.,
    3. Graf, E.,
    4. Zimmermann, F. A.,
    5. Wieland, T.,
    6. Haberberger, B.,
    7. Superti-Furga, A.,
    8. Kirschner, J.,
    9. Steinmann, B.,
    10. Baumgartner, M. R.,
    11. et al.
    (2012). Lack of the mitochondrial protein acylglycerol kinase causes Sengers syndrome. Am. J. Hum. Genet. 90, 314–320.
    OpenUrlCrossRefPubMed
  38. ↵
    1. Michaud, S.,
    2. Morrow, G.,
    3. Marchand, J. and
    4. Tanguay, R. M.
    (2002). Drosophila small heat shock proteins: cell and organelle-specific chaperones? Prog. Mol. Subcell. Biol. 28, 79–101.
    OpenUrlPubMed
  39. ↵
    1. Miwa, S.,
    2. St-Pierre, J.,
    3. Partridge, L. and
    4. Brand, M. D.
    (2003). Superoxide and hydrogen peroxide production by Drosophila mitochondria. Free Radic. Biol. Med. 35, 938–948.
    OpenUrlCrossRefPubMedWeb of Science
  40. ↵
    1. Morrow, G.,
    2. Inaguma, Y.,
    3. Kato, K. and
    4. Tanguay, R. M.
    (2000). The small heat shock protein Hsp22 of Drosophila melanogaster is a mitochondrial protein displaying oligomeric organization. J. Biol. Chem. 275, 31204–31210.
    OpenUrlAbstract/FREE Full Text
  41. ↵
    1. Napoli, L.,
    2. Bordoni, A.,
    3. Zeviani, M.,
    4. Hadjigeorgiou, G. M.,
    5. Sciacco, M.,
    6. Tiranti, V.,
    7. Terentiou, A.,
    8. Moggio, M.,
    9. Papadimitriou, A.,
    10. Scarlato, G.,
    11. et al.
    (2001). A novel missense adenine nucleotide translocator-1 gene mutation in a Greek adPEO family. Neurology 57, 2295–2298.
    OpenUrl
  42. ↵
    1. Narula, N.,
    2. Zaragoza, M. V.,
    3. Sengupta, P. P.,
    4. Li, P.,
    5. Haider, N.,
    6. Verjans, J.,
    7. Waymire, K.,
    8. Vannan, M. and
    9. Wallace, D. C.
    (2011). Adenine nucleotide translocase 1 deficiency results in dilated cardiomyopathy with defects in myocardial mechanics, histopathological alterations, and activation of apoptosis. JACC Cardiovasc. Imaging 4, 1–10.
    OpenUrlCrossRefPubMedWeb of Science
  43. ↵
    1. Neuman-Silberberg, F. S. and
    2. Schüpbach, T.
    (1996). The Drosophila TGF-alpha-like protein Gurken: expression and cellular localization during Drosophila oogenesis. Mech. Dev. 59, 105–113.
    OpenUrlCrossRefPubMedWeb of Science
  44. ↵
    1. Noe, N.,
    2. Dillon, L.,
    3. Lellek, V.,
    4. Diaz, F.,
    5. Hida, A.,
    6. Moraes, C. T. and
    7. Wenz, T.
    (2013). Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy. Mitochondrion 13, 417–426.
    OpenUrlCrossRefPubMedWeb of Science
  45. ↵
    1. Palmieri, L.,
    2. Alberio, S.,
    3. Pisano, I.,
    4. Lodi, T.,
    5. Meznaric-Petrusa, M.,
    6. Zidar, J.,
    7. Santoro, A.,
    8. Scarcia, P.,
    9. Fontanesi, F.,
    10. Lamantea, E.,
    11. et al.
    (2005). Complete loss-of-function of the heart/muscle-specific adenine nucleotide translocator is associated with mitochondrial myopathy and cardiomyopathy. Hum. Mol. Genet. 14, 3079–3088.
    OpenUrlAbstract/FREE Full Text
  46. ↵
    1. Parker, L.,
    2. Padilla, M.,
    3. Du, Y.,
    4. Dong, K. and
    5. Tanouye, M. A.
    (2011). Drosophila as a model for epilepsy: bss is a gain-of-function mutation in the para sodium channel gene that leads to seizures. Genetics 187, 523–534.
    OpenUrlAbstract/FREE Full Text
  47. ↵
    1. Pavlidis, P.,
    2. Ramaswami, M. and
    3. Tanouye, M. A.
    (1994). The Drosophila easily shocked gene: a mutation in a phospholipid synthetic pathway causes seizure, neuronal failure, and paralysis. Cell 79, 23–33.
    OpenUrlCrossRefPubMedWeb of Science
  48. ↵
    1. Pebay-Peyroula, E.,
    2. Dahout-Gonzalez, C.,
    3. Kahn, R.,
    4. Trézéguet, V.,
    5. Lauquin, G. J. and
    6. Brandolin, G.
    (2003). Structure of mitochondrial ADP/ATP carrier in complex with carboxyatractyloside. Nature 426, 39–44.
    OpenUrlCrossRefPubMedWeb of Science
  49. ↵
    1. Phillips, M. J.,
    2. Webb-Wood, S.,
    3. Faulkner, A. E.,
    4. Jabbar, S. B.,
    5. Biousse, V.,
    6. Newman, N. J.,
    7. Do, V. T.,
    8. Boatright, J. H.,
    9. Wallace, D. C. and
    10. Pardue, M. T.
    (2010). Retinal function and structure in Ant1-deficient mice. Invest. Ophthalmol. Vis. Sci. 51, 6744–6752.
    OpenUrlAbstract/FREE Full Text
  50. ↵
    1. Poulton, J. S. and
    2. Deng, W. M.
    (2007). Cell-cell communication and axis specification in the Drosophila oocyte. Dev. Biol. 311, 1–10.
    OpenUrlCrossRefPubMed
  51. ↵
    1. Rikhy, R.,
    2. Ramaswami, M. and
    3. Krishnan, K. S.
    (2003). A temperature-sensitive allele of Drosophila sesB reveals acute functions for the mitochondrial adenine nucleotide translocase in synaptic transmission and dynamin regulation. Genetics 165, 1243–1253.
    OpenUrlAbstract/FREE Full Text
  52. ↵
    1. Rørth, P.
    (1998). Gal4 in the Drosophila female germline. Mech. Dev. 78, 113–118.
    OpenUrlCrossRefPubMedWeb of Science
  53. ↵
    1. Rørth, P.,
    2. Szabo, K. and
    3. Texido, G.
    (2000). The level of C/EBP protein is critical for cell migration during Drosophila oogenesis and is tightly controlled by regulated degradation. Mol. Cell 6, 23–30.
    OpenUrlCrossRefPubMedWeb of Science
  54. ↵
    1. Roth, S.,
    2. Neuman-Silberberg, F. S.,
    3. Barcelo, G. and
    4. Schüpbach, T.
    (1995). cornichon and the EGF receptor signaling process are necessary for both anterior-posterior and dorsal-ventral pattern formation in Drosophila. Cell 81, 967–978.
    OpenUrlCrossRefPubMedWeb of Science
  55. ↵
    1. Royden, C. S.,
    2. Pirrotta, V. and
    3. Jan, L. Y.
    (1987). The tko locus, site of a behavioral mutation in D. melanogaster, codes for a protein homologous to prokaryotic ribosomal protein S12. Cell 51, 165–173.
    OpenUrlCrossRefPubMedWeb of Science
  56. ↵
    1. Saada, A.
    (2004). Deoxyribonucleotides and disorders of mitochondrial DNA integrity. DNA Cell Biol. 23, 797–806.
    OpenUrlCrossRefPubMedWeb of Science
  57. ↵
    1. Sanz, A.,
    2. Soikkeli, M.,
    3. Portero-Otín, M.,
    4. Wilson, A.,
    5. Kemppainen, E.,
    6. McIlroy, G.,
    7. Ellilä, S.,
    8. Kemppainen, K. K.,
    9. Tuomela, T.,
    10. Lakanmaa, M.,
    11. et al.
    (2010a). Expression of the yeast NADH dehydrogenase Ndi1 in Drosophila confers increased lifespan independently of dietary restriction. Proc. Natl. Acad. Sci. USA 107, 9105–9110.
    OpenUrlAbstract/FREE Full Text
  58. ↵
    1. Sanz, A.,
    2. Fernández-Ayala, D. J.,
    3. Stefanatos, R. K. and
    4. Jacobs, H. T.
    (2010b). Mitochondrial ROS production correlates with, but does not directly regulate lifespan in Drosophila. Aging 2, 200–223.
    OpenUrlPubMedWeb of Science
  59. ↵
    1. Shah, Z. H.,
    2. O’Dell, K. M.,
    3. Miller, S. C.,
    4. An, X. and
    5. Jacobs, H. T.
    (1997). Metazoan nuclear genes for mitoribosomal protein S12. Gene 204, 55–62.
    OpenUrlCrossRefPubMedWeb of Science
  60. ↵
    1. Sharer, J. D.
    (2005). The adenine nucleotide translocase type 1 (ANT1): a new factor in mitochondrial disease. IUBMB Life 57, 607–614.
    OpenUrlCrossRefPubMedWeb of Science
  61. ↵
    1. Spelbrink, J. N.,
    2. Li, F. Y.,
    3. Tiranti, V.,
    4. Nikali, K.,
    5. Yuan, Q. P.,
    6. Tariq, M.,
    7. Wanrooij, S.,
    8. Garrido, N.,
    9. Comi, G.,
    10. Morandi, L.,
    11. et al.
    (2001). Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria. Nat. Genet. 28, 223–231.
    OpenUrlCrossRefPubMedWeb of Science
  62. ↵
    1. Srivastava, S.,
    2. Diaz, F.,
    3. Iommarini, L.,
    4. Aure, K.,
    5. Lombes, A. and
    6. Moraes, C. T.
    (2009). PGC-1alpha/beta induced expression partially compensates for respiratory chain defects in cells from patients with mitochondrial disorders. Hum. Mol. Genet. 18, 1805–1812.
    OpenUrlAbstract/FREE Full Text
  63. ↵
    1. Stein, D.,
    2. Cho, Y. S. and
    3. Stevens, L. M.
    (2013). Localized serine protease activity and the establishment of Drosophila embryonic dorsoventral polarity. Fly (Austin) 7, 161–167.
    OpenUrlPubMed
  64. ↵
    1. Strauss, K. A.,
    2. DuBiner, L.,
    3. Simon, M.,
    4. Zaragoza, M.,
    5. Sengupta, P. P.,
    6. Li, P.,
    7. Narula, N.,
    8. Dreike, S.,
    9. Platt, J.,
    10. Procaccio, V.,
    11. et al.
    (2013). Severity of cardiomyopathy associated with adenine nucleotide translocator-1 deficiency correlates with mtDNA haplogroup. Proc. Natl. Acad. Sci. USA 110, 3453–3458.
    OpenUrlAbstract/FREE Full Text
  65. ↵
    1. Subramaniam, V.,
    2. Golik, P.,
    3. Murdock, D. G.,
    4. Levy, S.,
    5. Kerstann, K. W.,
    6. Coskun, P. E.,
    7. Melkonian, G. A. and
    8. Wallace, D. C.
    (2008). MITOCHIP assessment of differential gene expression in the skeletal muscle of Ant1 knockout mice: coordinate regulation of OXPHOS, antioxidant, and apoptotic genes. Biochim. Biophys. Acta 1777, 666–675.
    OpenUrlPubMed
  66. ↵
    1. Suomalainen, A. and
    2. Kaukonen, J.
    (2001). Diseases caused by nuclear genes affecting mtDNA stability. Am. J. Med. Genet. 106, 53–61.
    OpenUrlCrossRefPubMedWeb of Science
  67. ↵
    1. Terhzaz, S.,
    2. Cabrero, P.,
    3. Chintapalli, V. R.,
    4. Davies, S. A. and
    5. Dow, J. A.
    (2010). Mislocalization of mitochondria and compromised renal function and oxidative stress resistance in Drosophila SesB mutants. Physiol. Genomics 41, 33–41.
    OpenUrlAbstract/FREE Full Text
  68. ↵
    1. Tiefenböck, S. K.,
    2. Baltzer, C.,
    3. Egli, N. A. and
    4. Frei, C.
    (2010). The Drosophila PGC-1 homologue Spargel coordinates mitochondrial activity to insulin signalling. EMBO J. 29, 171–183.
    OpenUrlAbstract/FREE Full Text
  69. ↵
    1. Toivonen, J. M.,
    2. O’Dell, K. M.,
    3. Petit, N.,
    4. Irvine, S. C.,
    5. Knight, G. K.,
    6. Lehtonen, M.,
    7. Longmuir, M.,
    8. Luoto, K.,
    9. Touraille, S.,
    10. Wang, Z.,
    11. et al.
    (2001). Technical knockout, a Drosophila model of mitochondrial deafness. Genetics 159, 241–254.
    OpenUrlAbstract/FREE Full Text
  70. ↵
    1. Tyynismaa, H.,
    2. Ylikallio, E.,
    3. Patel, M.,
    4. Molnar, M. J.,
    5. Haller, R. G. and
    6. Suomalainen, A.
    (2009). A heterozygous truncating mutation in RRM2B causes autosomal-dominant progressive external ophthalmoplegia with multiple mtDNA deletions. Am. J. Hum. Genet. 85, 290–295.
    OpenUrlCrossRefPubMedWeb of Science
  71. ↵
    1. Van Goethem, G.,
    2. Dermaut, B.,
    3. Löfgren, A.,
    4. Martin, J. J. and
    5. Van Broeckhoven, C.
    (2001). Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions. Nat. Genet. 28, 211–212.
    OpenUrlCrossRefPubMedWeb of Science
  72. ↵
    1. Veal, E. and
    2. Day, A.
    (2011). Hydrogen peroxide as a signaling molecule. Antioxid. Redox Signal. 15, 147–151.
    OpenUrlCrossRefPubMedWeb of Science
  73. ↵
    1. Wang, X.,
    2. Salinas, K.,
    3. Zuo, X.,
    4. Kucejova, B. and
    5. Chen, X. J.
    (2008). Dominant membrane uncoupling by mutant adenine nucleotide translocase in mitochondrial diseases. Hum. Mol. Genet. 17, 4036–4044.
    OpenUrlAbstract/FREE Full Text
  74. ↵
    1. Wang, Y.,
    2. Ebermann, L.,
    3. Sterner-Kock, A.,
    4. Wika, S.,
    5. Schultheiss, H. P.,
    6. Dörner, A. and
    7. Walther, T.
    (2009). Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice. Exp. Physiol. 94, 220–227.
    OpenUrlCrossRefPubMedWeb of Science
  75. ↵
    1. Wenz, T.,
    2. Diaz, F.,
    3. Spiegelman, B. M. and
    4. Moraes, C. T.
    (2008). Activation of the PPAR/PGC-1alpha pathway prevents a bioenergetic deficit and effectively improves a mitochondrial myopathy phenotype. Cell Metab. 8, 249–256.
    OpenUrlCrossRefPubMedWeb of Science
  76. ↵
    1. Yamamoto, M.,
    2. Uematsu, S.,
    3. Okamoto, T.,
    4. Matsuura, Y.,
    5. Sato, S.,
    6. Kumar, H.,
    7. Satoh, T.,
    8. Saitoh, T.,
    9. Takeda, K.,
    10. Ishii, K. J.,
    11. et al.
    (2007). Enhanced TLR-mediated NF-IL6 dependent gene expression by Trib1 deficiency. J. Exp. Med. 204, 2233–2239.
    OpenUrlAbstract/FREE Full Text
  77. ↵
    1. Zhang, Y. Q.,
    2. Roote, J.,
    3. Brogna, S.,
    4. Davis, A. W.,
    5. Barbash, D. A.,
    6. Nash, D. and
    7. Ashburner, M.
    (1999). stress sensitive B encodes an adenine nucleotide translocase in Drosophila melanogaster. Genetics 153, 891–903.
    OpenUrlAbstract/FREE Full Text
  78. ↵
    1. Zhang, H.,
    2. Tan, J.,
    3. Reynolds, E.,
    4. Kuebler, D.,
    5. Faulhaber, S. and
    6. Tanouye, M.
    (2002). The Drosophila slamdance gene: a mutation in an aminopeptidase can cause seizure, paralysis and neuronal failure. Genetics 162, 1283–1299.
    OpenUrlAbstract/FREE Full Text
View Abstract
Previous ArticleNext Article
Back to top
Previous ArticleNext Article

This Issue

RSSRSS

Keywords

  • Adenine nucleotide translocase
  • Mitochondrial disease
  • Mitochondrial biogenesis
  • Alternative oxidase

 Download PDF

Email

Thank you for your interest in spreading the word on Disease Models & Mechanisms.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Phenotypic rescue of a Drosophila model of mitochondrial ANT1 disease
(Your Name) has sent you a message from Disease Models & Mechanisms
(Your Name) thought you would like to see the Disease Models & Mechanisms web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Research Article
Phenotypic rescue of a Drosophila model of mitochondrial ANT1 disease
Suvi Vartiainen, Shanjun Chen, Jack George, Tea Tuomela, Kaisa R. Luoto, Kevin M. C. O’Dell, Howard T. Jacobs
Disease Models & Mechanisms 2014 7: 635-648; doi: 10.1242/dmm.016527
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Research Article
Phenotypic rescue of a Drosophila model of mitochondrial ANT1 disease
Suvi Vartiainen, Shanjun Chen, Jack George, Tea Tuomela, Kaisa R. Luoto, Kevin M. C. O’Dell, Howard T. Jacobs
Disease Models & Mechanisms 2014 7: 635-648; doi: 10.1242/dmm.016527

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Alerts

Please log in to add an alert for this article.

Sign in to email alerts with your email address

Article navigation

  • Top
  • Article
    • Abstract
    • INTRODUCTION
    • RESULTS
    • DISCUSSION
    • MATERIALS AND METHODS
    • Acknowledgements
    • Footnotes
    • References
  • Figures & tables
  • Supp info
  • Info & metrics
  • PDF + SI
  • PDF

Related articles

Cited by...

More in this TOC section

  • Heterogeneity in clone dynamics within and adjacent to intestinal tumours identified by Dre-mediated lineage tracing
  • Inducible expression of human C9ORF72 36x G4C2 hexanucleotide repeats is sufficient to cause RAN translation and rapid muscular atrophy in mice
  • Neural crest-specific deletion of Bmp7 leads to midfacial hypoplasia, nasal airway obstruction, and disordered breathing modelling Obstructive Sleep Apnea
Show more RESEARCH ARTICLE

Similar articles

Subject collections

  • Metabolic Disorders
  • Drosophila as a Disease Model

Other journals from The Company of Biologists

Development

Journal of Cell Science

Journal of Experimental Biology

Biology Open

Advertisement

DMM and COVID-19

We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.

Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.


Professor Elizabeth Patton appointed as DMM’s next Editor-in-Chief

We are pleased to announce that The Company of Biologists directors have appointed Professor Elizabeth Patton as DMM's new Editor-in-Chief. As Paresh Vyas writes in his Editorial, Liz ‘brings vitality and a passion for the remit of DMM, and is deeply embedded in the community.’


Did you know DMM Conference Travel Grants can be used for online meetings?

With travel restrictions still in place, we want to continue supporting early-career researchers in their careers. DMM’s Conference Travel Grants can now be used to attend virtual and online scientific meetings, workshops, conferences and training courses.

The current application round closes on 8 February 2021 – find out more.


Identification of MYOM2 as a candidate gene in hypertrophic cardiomyopathy and Tetralogy of Fallot, and its functional evaluation in the Drosophila heart

Research from Silke Sperling and colleagues uses Drosophila to identify MYOM2 as a candidate gene in congenital heart malformations in this issue’s Editor’s choice.


C. elegans as a disease model

A new Research article from Doyle et al., models spinal muscular atrophy in C. elegans to show that that targeting therapies to muscle cells is more effective than neuronal delivery. Find more research using C. elegans as a disease model in our latest subject collection.


Call for papers – The RAS Pathway: Diseases, Therapeutics and Beyond

Our upcoming special issue is now welcoming submissions until 1 April 2021. Guest-edited by Donita Brady (Perelman School of Medicine at the University of Pennsylvania, USA) and Arvin Dar (Icahn School of Medicine at Mount Sinai, USA), the issue will focus on the targeting the RAS pathway. Find out more about the issue and how to submit your manuscript.


Interview – Kim Landry-Truchon and Nicolas Houde

In an interview, first authors Kim Landry-Truchon and Nicolas Houde discuss their mouse model of the early stages of pleuropulmonary blastoma, reflecting on the implications of their work and the future of their field.

Articles

  • Accepted manuscripts
  • Issue in progress
  • Latest complete issue
  • Issue archive
  • Archive by article type
  • Subject collections
  • Interviews
  • Sign up for alerts

About us

  • About DMM
  • Editors and Board
  • Editor biographies
  • Travelling Fellowships
  • Grants and funding
  • Journal Meetings
  • Workshops
  • The Company of Biologists

For Authors

  • Submit a manuscript
  • Aims and scope
  • Presubmission enquiries
  • Article types
  • Manuscript preparation
  • Cover suggestions
  • Editorial process
  • Promoting your paper
  • Open Access
  • Biology Open transfer

Journal Info

  • Journal policies
  • Rights and permissions
  • Media policies
  • Reviewer guide
  • Sign up for alerts

Contact

  • Contact DMM
  • Advertising
  • Feedback

Twitter   YouTube   LinkedIn

© 2021   The Company of Biologists Ltd   Registered Charity 277992